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Cardiac conduction is mediated by gap junction channels that are formed by connexin
(Cx) protein subunits. The connexin family of proteins consists of more than 20 members
varying in their biophysical properties and ability to combine with other connexins into
heteromeric gap junction channels. The mammalian heart shows regional differences both
in connexin expression profile and in degree of electrical coupling. The latter reflects
functional requirements for conduction velocity which needs to be low in the sinoatrial
and atrioventricular nodes and high in the ventricular conduction system. Over the past 20
years knowledge of the biology of gap junction channels and their role in the genesis of
cardiac arrhythmias has increased enormously. This review focuses on the insights gained
from transgenic mouse models. The mouse heart expresses Cx30, 30.2, 37, 40, 43, 45,
and 46. For these connexins a variety of knock-outs, heart-specific knock-outs, conditional
knock-outs, double knock-outs, knock-ins and overexpressors has been studied. We
discuss the cardiac phenotype in these models and compare Cx expression between
mice and men. Mouse models have enhanced our understanding of (patho)-physiological
implications of Cx diversity in the heart. In principle connexin-specific modulation of
electrical coupling in the heart represents an interesting treatment strategy for cardiac
arrhythmias and conduction disorders.
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INTRODUCTION
Gap junction channels form continuous pores between the cyto-
plasms of closely apposed cells that are permeable to ions and
molecules <1 kDa, thereby conferring electrical and metabolic
coupling between neighboring cells. Gap junction channels con-
sist of connexin (Cx) protein subunits. More than 20Cx isoforms
have been described in both humans and mice and mutations
in Cx genes have been implicated in various inheritable dis-
eases (Sohl andWillecke, 2004; Dobrowolski andWillecke, 2009).
Complete gap junction channels are formed by the docking of two
hemichannels, or connexons, contributed by closely apposed cells
(Figure 1). Each connexon consists of 6 connexin subunits, and
a homomeric gap junction channel consists of 12 Cx proteins of
the same isoform.When two homomeric connexons consisting of
different connexins are apposed, a heterotypic channel may form
if those connexins are compatible. In heteromeric connexons, dif-
ferent isoforms are mixed, and a heteromeric channel may form.
Some Cxs also form functional hemichannels, i.e., connexons that
can open under certain conditions, causing depolarization of the
plasma membrane (John et al., 1999; Bukauskas et al., 2006).
Different regions of the heart show specific profiles of Cx
expression, which in mouse and human hearts show many simi-
larities, but also some important differences (Table 1). Different
parts of the heart also have varying requirements for the degree
of electrical coupling. To spread the activation wave rapidly over
the ventricles, the large Purkinje myocytes of the specialized ven-
tricular conduction system need to be strongly coupled. To create
a delay between the atrial and ventricular contraction, a very low
degree of coupling is required in the atrioventricular (AV) node.
Similarly, to allow pacemaker function, pacemaker myocytes in
the sinoatrial (SA) node need to be weakly coupled, otherwise
the pacemaker (or ectopic focus) would in effect be silenced by
the surrounding working myocardium (Joyner and van Capelle,
1986; Joyner et al., 2000).
Cardiac gap junctions are highly dynamic structures, with a
Cx43 protein half-life of a few hours and a comparably rapid
redistribution in response to e.g., ischemia (Beardslee et al., 1998;
Smyth et al., 2012). Connexins interact directly with numerous
other cellular proteins, e.g., cytoskeletal components (Herve et al.,
2007). Apart from their well-established roles in electrical and
metabolic coupling, a number of other functions of Cx proteins
are emerging, for example in mechanical adhesion and inter-
actions with voltage-gated membrane channels (Agullo-Pascual
and Delmar, 2012) and, in the case of Cx43, in mitochondrial
metabolism (Ruiz-Meana et al., 2008). Conversely, electrical cou-
plingmay bemediated not only by gap junction channels, but also
to some degree by ephaptic coupling, i.e., by electric field effects
(Sperelakis, 2002; Lin and Keener, 2010).
Connexins differ in various biophysical properties, such as sin-
gle channel conductance, permeability to larger (dye) molecules
and sensitivity to the cytoplasmic pH and transjunctional poten-
tial difference, (see e.g., Elfgang et al., 1995; Gonzalez et al.,
2007; Rackauskas et al., 2010). Concerning the latter, gap junction
channels may close during prolonged, large voltage differences
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FIGURE 1 | Gap junction channels. (A) Schematic representation of a gap
junctional plaque, with each of the neighboring cells contributing one
hemichannel to form the complete gap junction channel. (B) Structure of the
pattern of a single connexin subunit with 4 domains traversing the
membrane. (C) A hemichannel or connexon consists of a hexagonal
arrangement of 6 Cx subunits, either of the same Cx isoform (homomeric
connexon) or of different isoforms (heteromeric connexon). (D) Gap junction
channels formed by homomeric connexons of the same isoform (homomeric
channel), by homomeric connexons of different isoforms (heterotypic
channel) or by heteromeric connexons (heteromeric channels).
between cells, for example when one myocyte fires an action
potential while its direct neighbor remains at rest (Lin and
Veenstra, 2004; Lin et al., 2005). While such large voltage gra-
dients can be imposed in voltage clamp experiments, they are
unlikely to occur in the heart. Even in regions with a rela-
tively low degree of electrical coupling, such as the SA node,
transjunctional potential differences >10mV last only a few mil-
liseconds (Verheule et al., 2001), which would be too short for the
slow process of voltage-dependent inactivation of gap junction
channels.
Cx trafficking, degradation, channel gating and permeabil-
ity can be regulated by phosphorylation of serine and tyrosine
residues (Solan and Lampe, 2009). During ischemia, intracel-
lular acidification, release of lipids and channel phosphoryla-
tion cause channel closure and redistribution (Dhein, 2006).
This response to ischemia allows the confinement of dis-
eased from healthy myocardium, thus enabling the myocardium
to “heal-over” (de Mello et al., 1969). On the other hand,
redistribution of connexins under pathological conditions has
been implicated in arrhythmogenesis (Salameh and Dhein, 2011;
Duffy, 2012).
Much of our current knowledge of cardiac connexins stems
from studies on mouse models (Table 2). There are numer-
ous similarities, but also some important differences between
the hearts of mice and humans (Kaese and Verheule, 2012).
In this review, we will discuss evidence from genetically engi-
neered mouse models on the properties and roles of the various
cardiac connexins, highlighting both their role during cardiac
development and in the adult heart.
CONNEXIN 30
Cx30 forms channels with a large single channel conductance (γj)
of 179 pS (in K-aspartate), a potential of half-maximal inactiva-
tion (V1/2) of 27mV and a voltage-independent fraction (Gj, min)
of 0.15 (Valiunas et al., 1999). Cx30 is expressed at low abundance
in the murine SA node (Gros et al., 2010). Interestingly, Cx30-
deficient mice have a 9% higher heart rate than wild type (Wt)
mice and a lower beat-to-beat variability (Gros et al., 2010). This
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Table 1 | Comparison of Cx regional expression in the mouse and human heart.
Mouse References Human References
SA node Cx45, Cx30.2,
(Cx30, Cx46)
Verheijck et al., 2001; Kreuzberg et al.,
2005; Chi et al., 2010; Gros et al., 2010
Cx45, Cx40 Davis et al., 1995; Chandler et al.,
2009; Kreuzberg et al., 2009
Atria Cx40, Cx43,
((Cx45))
Delorme et al., 1995, 1997; Alcoléa et al.,
2004; Miquerol et al., 2004
Cx40, Cx43,
(Cx45)
Davis et al., 1995; Vozzi et al., 1999;
Kanagaratnam et al., 2002; Kreuzberg
et al., 2009; Greener et al., 2011
AV node (compact) Cx45, Cx30.2 Coppen et al., 2001; Miquerol et al., 2004;
Kreuzberg et al., 2006
Cx40, Cx45 Davis et al., 1995; Kreuzberg et al.,
2009; Greener et al., 2011
His bundle Cx40, Cx45,
(Cx30.2, Cx46)
Simon et al., 1998; Coppen et al., 1999,
2001; Kreuzberg et al., 2006; Chi et al.,
2010
Cx40, Cx43 Hucker et al., 2008; Greener et al.,
2011
Bundle branches Cx40, Cx45,
(Cx46)
Simon et al., 1998; Coppen et al., 1999,
2001; van Rijen et al., 2001; Chi et al., 2010
Cx45 Davis et al., 1995; Coppen et al.,
2003; Kreuzberg et al., 2009; Greener
et al., 2011
Distal Purkinje system Cx40, Cx43,
Cx45, (Cx46)
Coppen et al., 1999; Miquerol et al., 2003;
Chi et al., 2010
Cx40, Cx43,
(Cx45)
van Kempen et al., 1995; Coppen
et al., 2003; Kreuzberg et al., 2009
Ventricles Cx43, ((Cx45)) Delorme et al., 1997; Stein et al., 2009; Bao
et al., 2011
Cx43, (Cx45) Davis et al., 1995; Vozzi et al., 1999;
Dupont et al., 2001; Kreuzberg et al.,
2009; Greener et al., 2011
(Cx) and ((Cx)) signify relatively small and trace amounts.
increased rate was still present under autonomic blockade, indi-
cating that Cx30 affects the intrinsic pacemaker frequency. The
presence of Cx30 could conceivably enhance electrical coupling
between the SA node and the surrounding atrium and thereby
decelerate impulse formation within the SA node (Dhein, 2010;
Gros et al., 2010). However, it is not known whether Cx30 in the
SA node forms heteromeric gap junction channels with the other
connexins present (Cx30.2 and Cx45), and whether this would
increase or decrease cell-to-cell electrical coupling.
CONNEXIN 30.2
Cx30.2, the murine ortholog of human Cx31.9 (Belluardo et al.,
2001), forms small conductance, weakly voltage-dependent chan-
nels [γj = 9 pS, V1/2 > 60mV (Kreuzberg et al., 2005)]. Cx30.2
is expressed in the murine SA node, AV node and His bundle
(Kreuzberg et al., 2005). In transfected HeLa cells, Cx30.2 can
form both heterotypic (Kreuzberg et al., 2005) and heteromeric
(Gemel et al., 2008) channels with Cx40, Cx43, and Cx45, the
major myocardial connexins. Cx30.2 was colocalized with Cx45
in the SA and AV nodes, but not with Cx40 and Cx43 (Kreuzberg
et al., 2005). Surprisingly, Cx30.2 deficient mice display acceler-
ated AV nodal conduction, a decrease in AV Wenckebach period
and a higher ventricular rate during atrial fibrillation (Kreuzberg
et al., 2006). In addition, whereas deletion of Cx40 slows AV con-
duction, it is normal in mice deficient for both Cx30.2 and Cx40
(Schrickel et al., 2009), suggesting that the balance between Cx40
and Cx30.2 is an important determinant of AV conduction in
mice. Cx30.2 is able to form functional hemichannels (Bukauskas
et al., 2006), which in the open state would decrease the mem-
brane resistance and thereby slow conduction, but the role of
these hemichannels in the adult heart is uncertain at present.
During development, Cx30.2 expression and proper develop-
ment of the AV conduction system is determined by an enhancer
region under the control of Tbx5 and GATA4. Accordingly, the
PR interval is shortened in GATA4+/− mice (Munshi et al.,
2009). Moreover, inhibition of Notch signaling during develop-
ment leads to a loss of Cx30.2 expressing cells, hypoplasia of the
AV node and accelerated AV conduction (Rentschler et al., 2011).
It is important to note that Cx31.9, the human ortholog ofmurine
Cx30.2, is not expressed in the human SA andAVnodes, ventricu-
lar conduction system or working myocardium (Kreuzberg et al.,
2009). This indicates that the presence of Cx30.2 may reflect an
adaptation in the small mouse heart to allow high activation fre-
quencies and optimize A-V timing. In addition to this difference,
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Table 2 | Overview of genetically engineered mouse models.
Type Model Initial description
Knock-out Cx30−/− Gros et al., 2010
Cx30.2−/− Kreuzberg et al., 2006
Cx37−/− Simon et al., 1997;
Munger et al., 2013
Cx40−/− Kirchhoff et al., 1998;
Simon et al., 1998
Cx43−/− Reaume et al., 1995
Cx45−/− Kumai et al., 2000
Cx46−/− Chi et al., 2010
Conditional
Knockout
Cx43 inducible Eckardt et al., 2004
Cx43 heart-specific Gutstein et al., 2001a
Cx43 chimera Gutstein et al., 2001b
Cx45 heart-specific Frank et al., 2012
Overexpression Cx43 Ewart et al., 1997
Cx45 Betsuyaku et al., 2006
Double
knock-outs
Cx30.2−/−–Cx40−/− Schrickel et al., 2009
Cx30.2−/−–Cx45inducible Frank et al., 2012
Cx32−/−–Cx43−/− Houghton et al., 1999
Cx37−/−–Cx40−/− Simon et al., 2004
Cx40−/−–Cx43−/− and +/− Kirchhoff et al., 2000;
Simon et al., 2004
Cx40−/−–Cx45+/− Kruger et al., 2006
Knock-ins Cx40 KI Cx45 Alcoléa et al., 2004
Cx43 KI Cx26 Winterhager et al., 2007
Cx43 KI Cx31 Zheng-Fischhofer et al.,
2006
Cx43 KI Cx32 Plum et al., 2000
Cx43 KI Cx40 Plum et al., 2000
Cx45 KI Cx36 Frank et al., 2010
Mutants Cx43 K258stop Maass et al., 2004, 2007
Cx43 S325/328/330 E or A Remo et al., 2011
Cx43 I130T Kalcheva et al., 2007
Cx43 G138R Dobrowolski et al., 2008
Cx43 G60S Flenniken et al., 2005;
Manias et al., 2008
AV conduction system in the mouse is also electrically connected
to the ventricles at the basal part of the septum, leading to a
baso-apical activation pattern within the septum (van Rijen et al.,
2001).
CONNEXIN 37
Cx37 forms large conductance channels that are moderately volt-
age sensitive [γj = 200–250 pS in K-glutamate, V1/2 = 28mV,
Gj, min = 0.27 (Reed et al., 1993)]. In the adult heart, Cx37 is
expressed by endothelial cells in blood vessels and the endo-
cardial lining of the chambers, although expression has also
been observed in parts of the ventricular myocardium during
embryonic development (Haefliger et al., 2000). Cx37−/− mice
do not develop venous and lymphatic valves (Munger et al., 2013).
In addition, mice lacking both Cx37 and Cx40 show a high inci-




Cx40 forms channels with a large single channel conductance and
moderate voltage-sensitivity [γj = 150 pS in KCl, V1/2 = 44mV,
Gj, min = 0.5 (Traub et al., 1994)]. In the developingmouse heart,
Cx40 is widely expressed in the ventricles and atria at embry-
onic day 11. From day 14 onwards, Cx40 becomes restricted to
the conduction system in the ventricles, but it remains present
in the atrial working myocardium (Delorme et al., 1995). The
transcription factors Tbx2 and Tbx3 repress Cx40 expression
(Hoogaars et al., 2004; Aanhaanen et al., 2011). Inactivation of
Tbx2 leads to the formation of Cx40-expressing accessory path-
ways and ventricular preexcitation (Aanhaanen et al., 2011). On
the other hand, Cx40 expression is increased by Nkx2-5 (Harris
et al., 2006) and Tbx5 (Pizard et al., 2005; Arnolds et al., 2012)
that delineate the conduction system. In fact, normal develop-
ment of the ventricular conduction system requires the expression
of Cx40 (Sankova et al., 2012).
In the adult mouse heart, Cx40 is expressed by atrial myocytes
and ventricular conduction system (His bundle, left and right
bundle branches and Purkinje network) (Simon et al., 1998;
Miquerol et al., 2004; van Veen et al., 2005b). The selective expres-
sion of Cx40 by the conduction system within the ventricle has
allowed sophisticated functional studies on conduction within the
Purkinje network (Miquerol et al., 2004; Tallini et al., 2007).
ATRIA
Information on the effect of Cx40-deficiency on atrial conduc-
tion is somewhat contradictory. In the first studies, the P wave
duration was significantly prolonged (Kirchhoff et al., 1998;
Simon et al., 1998; Hagendorff et al., 1999; Verheule et al., 1999;
Bagwe et al., 2005). Some other studies have not reproduced
this observation (Bevilacqua et al., 2000; Tamaddon et al., 2000;
Vanderbrink et al., 2000). Measurement of P-wave duration in
mice is not straightforward, requiring different leads to accurately
determine the end of the biphasic P-wave. In two studies that
measured atrial conduction directly using direct contact map-
ping or optical mapping, a reduction in conduction velocity was
observed (Verheule et al., 1999; Bagwe et al., 2005). However, a
later study used optical mapping to show that deletion of Cx40
did not affect conduction velocity, but did abolish the difference
in conduction velocity between the left and right atria (Leaf et al.,
2008).
Atrial myocytes express both Cx40 and 43. Based on expression
studies in Xenopus oocytes, Cx40 and 43 were originally thought
to be incompatible (White and Bruzzone, 1996). However, later
studies presented compelling evidence that Cx40 and 43 can
form both heterotypic (Valiunas et al., 2000) and heteromeric
(He et al., 1999; Cottrell and Burt, 2001) gap junction chan-
nels in mammalian cells, including adult atrial myocytes (Elenes
et al., 1999). In cultured neonatal mouse atrial myocytes, Cx40
Frontiers in Pharmacology | Pharmacology of Ion Channels and Channelopathies June 2013 | Volume 4 | Article 81 | 4
Verheule and Kaese Connexins in the mouse heart
and 43 appear to make equal contributions to total gap junc-
tional conductance (Lin et al., 2010). Intriguingly, a study on
cultured strands of atrial myocytes that the Cx40/Cx43 ratio was
an important determinant of propagation, with Cx43 increas-
ing and Cx40 decreasing conduction velocity (Beauchamp et al.,
2006).
In intact Cx40−/− mice, episodes of atrial tachyarrythmias/
atrial fibrillation could be induced by transesophageal pacing
(Hagendorff et al., 1999) and direct atrial pacing (Verheule et al.,
1999; Bevilacqua et al., 2000). In perfused Cx40−/− mouse hearts
studied with optical mapping, atrial ectopic beats and intraa-
trial conduction block during pacing at high rates were reported
(Bagwe et al., 2005).
SINOATRIAL NODE
In contrast to larger species, such as rabbits (Verheule et al.,
2001), pacemaker myocytes in the central SA node do not express
Cx40 (Verheijck et al., 2001; Wiese et al., 2009) However, Cx40-
deficiency does cause a modest increase in sinus cycle length
(Hagendorff et al., 1999; Verheule et al., 1999; Bevilacqua et al.,
2000; de Wit et al., 2003), and an increase in (corrected) SA node
recovery time (Hagendorff et al., 1999; Verheule et al., 1999). The
effects of Cx40-deficiency on SA node function may be caused
either by altered conduction from the SA node to the atrium and/
or by the phenomenon that the “atrial pacemaking complex” may
bemuch larger than the area that is classically considered to be the
sinus node (Glukhov et al., 2010).
ATRIOVENTRICULAR CONDUCTION
AV conduction is also affected in Cx40−/− mice, reflected in a
prolonged PR interval, increased QRS duration and a QRS mor-
phology reminiscent of right bundle branch block in humans
(Kirchhoff et al., 1998; Simon et al., 1998; Verheule et al., 1999;
Bevilacqua et al., 2000; Vanderbrink et al., 2000). In addition,
episodes of 2nd and 3rd degree AV block were observed in
Cx40−/− mice (Kirchhoff et al., 1998; Hagendorff et al., 1999).
With minor differences between studies, Cx40-deficiency pro-
longs the AV effective refractory period (ERP), the cycle lengths of
A to V Wenckebach and 2:1 block, while the atrial ERP, ventricu-
lar ERP, cycle lengths of V to AWenckebach and 2:1 block are not
affected (Hagendorff et al., 1999; Verheule et al., 1999; Bevilacqua
et al., 2000; Vanderbrink et al., 2000). Although Cx40 is not
expressed in the central AV node (Delorme et al., 1995; Simon
et al., 1998; Coppen et al., 1999), the AH interval is prolonged
in intact mice (Bevilacqua et al., 2000; Vanderbrink et al., 2000),
AV nodal conduction curves are shifted (Vanderbrink et al., 2000)
and AV nodal facilitation is reversed (Zhu et al., 2005), indicative
of an effect on the AV node itself. However, AV nodal conduction
curves recorded in perfused hearts did not differ between Wt and
Cx40−/− mice (van Rijen et al., 2001), suggesting a possible role
of autonomic activity in the observations in intact mice.
Both the left and right bundle branch normally express high
levels of Cx40 (Simon et al., 1998; van Rijen et al., 2001). High
resolution mapping has revealed that deletion of Cx40 leads to
slower conduction in the left bundle branch and conduction
block in the thinner right bundle branch, causing a delayed activa-
tion of the right ventricle (Tamaddon et al., 2000; van Rijen et al.,
2001). Interestingly, in mice the common bundle (expressing
Cx40 and 45) is electrically connected to the base of the interven-
tricular septum (expressing Cx43) through a small transitional
zone expressing Cx43 and 45 (van Rijen et al., 2001; van Veen
et al., 2005b) This arrangement results in an activation pattern
within the septum from base to apex that is quite different from
the pattern in humans (Durrer et al., 1970).
VENTRICLES
In the ventricular myocardium, which expresses Cx43 but not
Cx40, conduction velocity is unaffected by Cx40-deficiency and
the inducibility of ventricular arrhythmias under normal condi-
tions was not increased (Verheule et al., 1999; Bevilacqua et al.,
2000; Tamaddon et al., 2000), although one study reported an
increased inducibility of ventricular tachycardia (VT) in Cx40−/−
mice during infusion of isoproterenol (Bevilacqua et al., 2000),
possibly involving the Purkinje system.
In none of the studies mentioned above did heterozygous
Cx40+/− mice display a electrophysiological phenotype that dif-
fered from Cx40+/+ mice, indicating that even a substantial
reduction in Cx40 protein does not greatly affect cardiac con-
duction in mice. Moreover, although it differs considerably in
its biophysical properties, Cx45 can replace Cx40 almost com-
pletely, because cardiac activation in Cx40KICx45 mice is normal,
except for a slower conduction velocity in the left atrium and right
bundle branch (Alcoléa et al., 2004).
Two factors complicate the interpretation of electrophysiolog-
ical data from Cx40−/− mice. First, although this was not noted
in the earliest studies, Cx40 deficient mice display a high inci-
dence of a variety of cardiac malformations, including ventricular
septal defects, tetralogy of Fallot, double-outlet right ventricles,
endocardial cushion and aortic arch defects (Kirchhoff et al.,
2000; Gu et al., 2003). The occurrence of cardiac malforma-
tions is exacerbated in mice in which a homozygous deletion of
Cx40 is combined with a heterozygous deletion of either Cx43
(Kirchhoff et al., 2000) or Cx45 (Kruger et al., 2006), leading
to neonatal lethality in the former and additional atrial defects
and further delayed AV conduction in the latter. Mice that are
homozygously deficient for both Cx40 and 43 die much earlier
than Cx43−/− mice, around embryonic day 12, with an abnor-
mal rotation of the ventricles (Simon et al., 2004). Second, apart
from expression by atrial myocytes and Purkinje cells, Cx40 is
also expressed by endothelial cells (Dahl et al., 1995), together
with Cx37. Interestingly, de Wit et al have reported that in
Cx40−/− mice, arterioles show spontaneous, irregular vasomo-
tion and that blood pressure is greatly increased from 90 to
120mmHg (de Wit et al., 2003). To what extent hypertension
in Cx40−/− mice is responsible for secondary changes in car-
diac pump function, autonomic regulation and electrophysiology




Cx43 forms channels with a single channel conductance of 120 pS
(in CsCl) and a modest voltage dependence (V1/2 = 60mV and
Gj, min = 0.4) (Elenes et al., 2001).
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In the developing mouse heart, Cx43 is specifically present in
the trabeculated parts of the ventricle at embryonic day 12.5, but
is abundantly expressed by the entire working myocardium later
on (Coppen et al., 2003; Miquerol et al., 2003). Cx43 expression
is suppressed by the transcription factors Tbx18 (specifying the
SA node), Tbx2 and Tbx3 (specifying the AV conduction system)
(Christoffels et al., 2004; Bakker et al., 2008; Kapoor et al., 2011;
Sizarov et al., 2011).
Cx43−/− mice die shortly after birth from respiratory failure
caused by a right ventricular outflow tract obstruction (Reaume
et al., 1995). Abnormal cardiac development is already visible
during the looping phase at embryonic day 10 (Ya et al., 1998).
The outflow tract defect can be traced back to the neural
crest, where abnormal p53 activation in Cx43−/− mice causes
apoptosis of primordial germ cells that would otherwise have
migrated to the heart (Lo et al., 1997; Francis and Lo, 2006). Both
a deficiency and an excess of Cx43 can derail this process (Ewart
et al., 1997; Huang et al., 1998), although it does not necessarily
depend on Cx43 expression in the neural crest itself (Kretz et al.,
2006). In addition to this defect, Cx43−/− (and Cx43+/−) mice
also show abnormal patterning of the main coronary arteries (Li
et al., 2002; Walker et al., 2005; Liu et al., 2006).
VENTRICULAR CONDUCTION
Using optical mapping in Cx43−/− mouse embryos, Vaidya et al
reported that ventricular conduction velocity was unaffected at
embryonic day 12.5, when Cx40 is still present abundantly in the
ventricle. At embryonic day 17.5 however, ventricular conduction
velocity was greatly reduced and ventricular arrhythmiaswere fre-
quently observed (Vaidya et al., 2001). Accordingly, gap junctional
coupling and conduction velocity are dramatically reduced in cul-
tured neonatal myocytes from Cx43−/− mice, which do not show
a compensatory increase in Cx40 and 45 (Beauchamp et al., 2004;
Vink et al., 2004).
In adult mice, Cx43 is expressed in the atrial and ventric-
ular working myocardium and in the distal Purkinje system
(Gourdie et al., 1991; Gros and Jongsma, 1996; van Veen et al.,
2005b). Within the ventricular wall, Cx43 expression is lower
in the epicardium than in deeper regions (Yamada et al., 2004).
Unlike Cx43−/− mice, Cx43+/− mice survive and age normally
(Betsuyaku et al., 2002), although ventricular and atrial level of
Cx43 protein are reduced by approximately 50% (Guerrero et al.,
1997; Thomas et al., 1998). There has been a debate about to
what extent this reduction in expression affects conduction, with
one group reporting a 50% reduction in ventricular conduction
velocity (Guerrero et al., 1997; Eloff et al., 2001), and another
group reporting no change (Morley et al., 2000). The latter result
is in better agreement with studies using mathematical mod-
els, which predict a weaker dependence of conduction velocity
on gap junctional coupling (Shaw and Rudy, 1997; Wiegerinck
et al., 2006) and a study on strands of cultured myocytes from
Cx43+/+ and Cx43+/− mice, which did not show a difference
in conduction velocity (Thomas et al., 2003). Moreover, two
later studies in adult mice with conditional deletion of Cx43
showed a reduction of conduction velocity by approximately
40% while Cx43 protein level was decreased by 90% (Gutstein
et al., 2001a; van Rijen et al., 2004). Conduction anisotropy and
heterogeneity were increased, especially in the RV. VT was read-
ily induced by pacing, often with a stable reentrant circuit in the
RV and fibrillatory conduction in the LV (van Rijen et al., 2004).
Telemetric recordings revealed that most mice die from arrhyth-
mic sudden death within weeks of the start of Cx elimination
(Gutstein et al., 2001a). By contrast, in a conditional knock-out
strain with a 50% reduction in Cx43, no change in conduc-
tion velocity was observed and no arrhythmias were inducible
(van Rijen et al., 2004).
Similar findings were reported in mice with a cardiac-specific
deletion with a gradual postnatal decline in Cx43 expression. At
birth, cardiac structure in these mice is normal (Eckardt et al.,
2006), but Cx43 protein decreases to 59% of control level at
25 days (without a change in conduction velocity) and 18% at
45 days (with a 50% decrease in conduction velocity). At the
latter stage, lethal VTs could be induced in 80% of the mice
(Danik et al., 2004). Interestingly, optical mapping during sinus
rhythm in this model revealed ectopic sites of ventricular acti-
vation caused by a paradoxical increase in conduction across
Purkinje-ventricular junctions (Morley et al., 2005). In another
approach, chimeric mice were produced with a patchy Cx43
expression pattern in the ventricles. In addition to a depressed
pump function, these mice showed heterogeneous ventricular
conduction and spontaneous non-sustained VT (Gutstein et al.,
2001b, 2005).
REPLACEMENT OF Cx43
Several studies have assessed whether the role of Cx43 can
be taken over by other Cxs, using knock-in mouse models in
which Cx43 was replaced by Cx40, 32, 31, or 26. Anatomically,
Cx43KI40 hearts showed no abnormalities at birth (apart from
mild hypertrophy in some mice), whereas Cx43KI32 hearts
showed a mild form of the RV outflow tract abnormalities
seen in Cx43−/− mice (Plum et al., 2000). ECG intervals in
adult Cx43KI32 and Cx43KI40 mice did not differ from those
in control mice. However, spontaneous ventricular extrasys-
toles were observed more frequently in Cx43KI40 mice than in
Cx43KI32 and control mice. In Cx43KI31 mice, the RV out-
flow tract obstruction is severe, cardiac conduction is markedly
slow and mice die within days after birth (Zheng-Fischhofer
et al., 2006). In this context it is worth noting that Cx31 is
highly restricted in its ability to form channels with other Cxs
(Elfgang et al., 1995). Neonatal Cx43KI26 mice do not have struc-
turally abnormal hearts, have only slightly decelerated cardiac
conduction, but died within weeks because of deficient lacta-
tion of their heterozygous mothers (Winterhager et al., 2007).
Adult Cx43KI26 mice (reared by foster mothers) showed a small
prolongation in His-to-ventricle conduction time and QRS dura-
tion. Thus, several connexins are able to replace Cx43 in the
developing and heatlhy adult heart to a large degree. However,
the consequences of replacing Cx43 may be more pronounced
under pathological conditions (see below for an example in
Cx43KI32 mice).
RESPONSE TO ISCHEMIA
In the ventricles, the closing of gap junction channels in response
to ischemia enables the myocardium to “heal-over” (de Mello
Frontiers in Pharmacology | Pharmacology of Ion Channels and Channelopathies June 2013 | Volume 4 | Article 81 | 6
Verheule and Kaese Connexins in the mouse heart
et al., 1969), but it is also associated with (phase 1b) arrhyth-
mias occurring 15–60min after the onset of ischemia (De
Groot and Coronel, 2004; Wit and Peters, 2012). During acute
ischemia, spontaneous and induced VT occurred more frequently
in Cx43+/− than in Cx43+/+ mice (Lerner et al., 2000). However,
infarct size in the weeks after coronary occlusion was smaller in
Cx43+/− mice (Kanno et al., 2003). At those later time points, the
incidence of spontaneous and induced VT did not differ between
Cx43+/− and Cx43+/+ mice, suggesting that effect of reduced
coupling is offset by the smaller infarct size (Betsuyaku et al.,
2004).
Cx43 hemichannels are present in the plasma membrane and
can open as a non-selective pore in response to metabolic inhibi-
tion, which would accelerate cell death (John et al., 1999; Kondo
et al., 2000). Gap 19, a peptide that prevents hemichannel open-
ing, without affecting gap junction channels, reduces ischemia/
reperfusion damage (Wang et al., 2013).
In addition, Cx43 is located in the nuclear membrane and in
subsarcolemmal mitochondria (Rodriguez-Sinovas et al., 2007;
Boengler et al., 2009). Ischemic preconditioning increases the lev-
els of mitochondrial Cx43 (Boengler et al., 2005) and accordingly,
ischemic preconditioning is lost in Cx43+/− mice (Schwanke
et al., 2002; Li et al., 2004). Cx43 is involved in mitochondrial K+
uptake (Miro-Casas et al., 2009) and respiration (Boengler et al.,
2012), forming hemichannels in the mitochondrial inner mem-
brane that interact with other proteins (Rodriguez-Sinovas et al.,
2007).
The carboxy terminus of the Cx43 protein is an important
regulatory domain, involved in e.g., the response to intracellu-
lar acidification (Duffy et al., 2004). A mutant with a C terminal
truncation shows a redistribution of Cx43 to the periphery of
larger, sparser gap junctions (Maass et al., 2007). After ischemia/
reperfusion, this mutant has larger infarcts and a higher inci-
dence of induced VT (Maass et al., 2009). Similarly, increased
gap junctional coupling by adenoviral transfection of the less
pH-sensitive Cx32 increases infarct size in mice with a coronary
occlusion (Prestia et al., 2011). Replacement of Cx43 with Cx32
has more complex effects (Rodriguez-Sinovas et al., 2010). Under
normal conditions, ATP levels were decreased and lactate lev-
els were increased in the myocardium of these Cx43KI32 mice.
Although infarct size following ischemia/ reperfusion was smaller,
protection by preconditioning was lost, indicating that Cx32 can-
not replace Cx43 in its role in mitochondrial metabolism and
preconditioning.
Cx43 MUTATIONS
Several models of mutations in Cx genes have been developed
that correspond to inherited diseases in humans, as reviewed
in (Dobrowolski and Willecke, 2009) and (Delmar and Makita,
2012). The G60S missense mutation in Cx43 acts in a domi-
nant negative way to cause oculodentodigital dysplasia, including
various cardiac manifestations (patent foramen ovale, reduced
cardiac function, a large decrease in Cx43 due to impaired traf-
ficking to the intercalated disc, a small decrease in ventricular
conduction velocity and a variety of ECG abnormalities, both
brady- and tachyarrhythmias) (Flenniken et al., 2005; Kalcheva
et al., 2007; Manias et al., 2008; Tuomi et al., 2011). The
G138R (Dobrowolski et al., 2008) and I130T (Kalcheva et al.,
2007) mutants show a similar phenotype of oculodentodigi-
tal dysplasia, including similar alterations in cardiac structure
and function. However, in the case of G138R, Cx43 traffick-
ing seems to be normal, but Cx43 (hemichannel) function is
reduced due to a loss of phosphorylation. The importance of
Cx43 phosphorylation is also underscored by a study on mice
with “phosphatase resistant” Cx43, in which serine residues 325,
328, and 330 are replaced by either phosphomimetic glutamine
(S3E) or non-phosphorylatable alanine (S3A) (Remo et al., 2011).
S3E mice were resistant to gap junctional remodeling in response
to transverse aortic constriction and showed a lower inducibil-
ity of VT than wildtype mice. Conversely, in S3A mice Cx43
was lost from the intercalated disc in response to transverse
aortic constriction and inducibility of VT was higher than in
wildtype mice.
INTERACTIONSWITH OTHER PROTEINS
Cx43 interacts with a number of other proteins. Whereas the
organizations of adherens junctions is not disrupted in the
absence of Cx43 (Gutstein et al., 2003), conversely a loss of
E-cadherin, N-cadherin, desmin or desmoplakin does greatly
decrease Cx43 in intercalated discs (Ferreira-Cornwell et al.,
2002; Gard et al., 2005; Kostetskii et al., 2005; Li et al., 2005;
Gomes et al., 2012). Among the many changes in gene expression
(directly or indirectly) caused by the absence of Cx43 (Iacobas
et al., 2005), potassium current also show regional alterations in
Cx43−/− mice, leading to proarrhythmic shortening of the action
potential duration (Danik et al., 2008), whereas sodium channel
function may (Desplantez et al., 2012; Jansen et al., 2012a) or may
not (Johnson et al., 1999) be affected. Short term (6 h) ventricular
pacing causes a decrease in Cx43 gene expression (Kontogeorgis
et al., 2008a), while the shift in potassium channel expression in
response to pacing was altered in Cx43+/− mice (Kontogeorgis
et al., 2008b).
Interestingly, inducible deletion of Cx43 leads to increased
fibrosis during aging and pressure overload because of enhanced
fibroblast activity, with a concomitant increase in conduction het-
erogeneity and vulnerability to VT (Jansen et al., 2012b). On the
other hand, TGFβ—dependent profibrotic signaling in response
to myocardial infarction is blunted in Cx43+/− mice compared
to Cx43+/+ mice, leading to a decrease in post-infarct fibro-
sis (Zhang et al., 2010b), probably because of the difference in
Cx43 expression in fibroblasts (Zhang et al., 2010a). With respect
to arrhythmogenesis, these and some other studies highlight the
clinically relevant conjunction of changes in excitability, electrical
coupling and structural remodeling (van Veen et al., 2005a; Stein




Cx45 forms channels with small conductance of 30 pS that are
the most sensitive to transjunctional voltage of all cardiac Cxs
(V1/2 = 13mV, Gj, min = 0.12) (Moreno et al., 1995). Cx45 is
the connexin expressed earliest in the developing heart, and
the only one present before embryonic day 9. Cx45-deficient
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mice develop conduction block and a cushion defect caused
by impairment of the epithelial-mesenchymal transformation of
the cardiac endothelium (Kumai et al., 2000). Mice with car-
diac myocyte-specific deletion of Cx45 do not have the cush-
ion defect, but still develop conduction block and also die at
around embryonic day 10 from pump failure (Nishii et al.,
2003). The function of Cx45 in early cardiac development can-
not be replaced by the neuronal connexin Cx36 (Frank et al.,
2010).
PACEMAKER AND CONDUCTION SYSTEM
During later embryonic development, Cx45 becomes increasingly
localized to pacemaker and conduction system Alcolea et al.,
1999; Coppen et al., 1999. In adult mice, Cx45 is the main
connexin in the central SA node, a region apposed by pro-
trusions of Cx40 and 43 positive atrial cells (Verheijck et al.,
2001). Nevertheless, the heart rate is unaffected in mice with
a heart-specific inducible Cx45 deletion (Frank et al., 2012).
Furthermore, Cx45 is expressed along the entire AV conduc-
tion system, including the AV node, His bundle, proximal
bundle branches and Purkinje system (Coppen et al., 1999;
van Veen et al., 2005b). In adult mice, the dependence of
AV conduction on the 3Cxs expressed in the AV node region
is complex. As noted above, mice deficient in Cx30.2 and
40 show accelerated and decelerated AV conduction, respec-
tively (Schrickel et al., 2009). Apparently, Cx45 is sufficient
for AV conduction, because mice deficient in both Cx30.2 and
40 show normal AV conduction (Schrickel et al., 2009). In
mice with a heart-specific, inducible deficiency in Cx45, AV
nodal conduction is slower than normal (Frank et al., 2012),
whereas atrial and ventricular conduction was not affected
(Bao et al., 2011). Interestingly, these mice also displayed a
posttranslational reduction of Cx30.2 expression in the con-
duction system. Combining the inducible deficiency in Cx45
with a deficiency in Cx30.2 further slowed AV nodal conduc-
tion (Frank et al., 2012). Although a heterozygous deletion of
Cx45 does not prolong the PR interval by itself, it does further
increase the observed PR prolongation in Cx40-deficient mice
(Kruger et al., 2006).
WORKING MYOCARDIUM
Cx45 was initially thought to be widely expressed in the mam-
malian working myocardium (Davis et al., 1994; Verheule et al.,
1997). Coppen et al later showed that this observation was mainly
caused by cross-reactivity of a Cx45 antibody with Cx43 (Coppen
et al., 1998). Low levels of Cx45 are expressed in the mouse ven-
tricular working myocardium, amounting to 0.3% of total gap
junction protein (Bao et al., 2011). Cx45 can form both het-
erotypic (Elenes et al., 2001) and heteromeric (Desplantez et al.,
2004) channels with Cx43. However, co-expression of Cx45 with
Cx43 appears to decrease the size of gap junctions (Grikscheit
et al., 2008). This phenomenon could be more important under
conditions with a higher Cx45/Cx43 ratio, for example in the ven-
tricular epicardium, where Cx43 levels are relatively low (Yamada
et al., 2004), or during heart failure, where the expression of
Cx45 increases and Cx43 decreases (Yamada et al., 2003). Indeed,
mice overexpressing Cx45 in the heart showed a reduction in
gap junctional coupling and an increased inducibility of VT
(Betsuyaku et al., 2006).
CONNEXIN 46
Along with Cx50, Cx46 is the main connexin expressed in
the lens, forming channels with a γj = 140 pS in CsCl, V1/2 =
48mV, Gj, min = 0.11 (Hopperstad et al., 2000). mRNA for Cx46
(and Cx50) has been detected in the adult canine heart (Davis
et al., 1994). The localization of Cx46 (and Cx50) protein in
the dog heart is unknown, although one study detected min-
imal Cx46 immunoreactivity between some atrial and ventric-
ular myocytes (Davis et al., 1995). However, in neonatal mice
Cx46-positive myocytes were detected in the cardiac conduction
system (or more precisely in the atrium, AV canal, intraven-
tricular septum and ventricular subendocardium) (Chi et al.,
2010). Cx46-deficient mice displayed a slightly lower heart rate,
a prolonged QRS and QT duration and a QRS morphology con-
sistent with bundle branch block (Chi et al., 2010). Cx46 has
a propensity to form functional hemichannels (Trexler et al.,
1996; Pfahnl and Dahl, 1999), but their role in the heart is
unknown.
CONCLUSIONS
The diversity of connexins in the heart allows fine-tuning of
electrical coupling depending on the region and on conditions.
As therapeutic strategies, both increasing and decreasing gap
junctional coupling could in theory be beneficial under cer-
tain circumstances. However, a non-specific treatment target-
ing gap junctions may have beneficial effects in one part of
the heart but cause deleterious side effects in another. Several
compounds have been developed that can modulate gap junc-
tions (Herve and Dhein, 2010; De Vuyst et al., 2011). Some of
these have been successfully tested in animal models. For exam-
ple, in canine model of heart failure, enhancing gap junctional
coupling with rotigaptide can reduce the vulnerability to atrial
fibrillation (Guerra et al., 2006). For more selective pharmaco-
logical manipulation of gap junction coupling, it is desirable
for a treatment to be (1) specific to the heart and/or (2) spe-
cific for a particular connexin. In this respect, gap junction
blocking “peptidomimetics,” a class of small peptide molecules
that have some Cx selectivity, are especially promising (Evans
et al., 2012). An enormous amount of knowledge on cardiac
connexins has been gathered from genetically engineered mouse
models, as described above. There are some important dif-
ferences in cardiac electrophysiology in general and connexin
distribution in particular between murine and human hearts
(Kaese and Verheule, 2012). Nevertheless, for the development
of connexin-specific treatment strategies, knowledge derived
from transgenic mouse models provides a wealth of valuable
insights.
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